» Articles » PMID: 22975937

Detection of Microvascularization of Thyroid Carcinomas Using Linear High Resolution Contrast-enhanced Ultrasonography (CEUS)

Overview
Publisher Sage Publications
Date 2012 Sep 15
PMID 22975937
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Preoperative differentiation of thyroid nodules in benign and malignant pathologies still represents an unsolved problem in endocrinology. In the presented study, contrast-enhanced ultrasonography (CEUS) was applied as a new diagnostic tool detecting the microvascularisation of thyroid carcinomas.

Methods: 167 patients underwent surgery for suspicious thyroid nodules between 05/2011 and 08/2012. Contrast-enhanced ultrasonography (CEUS) with a linear probe (6-9 MHz, LOGIQE9/GE), color coded Doppler sonography (CCDS) and Power Doppler ultrasonography (PD) were performed in all patients preoperatively. Removed nodules were proved by histology. In case of carcinoma morphological characteristics and especially microvascularization were analyzed using time intensity curves (TIC) in selected regions of interest (ROI).

Results: In total, 22 thyroid carcinomas could be identified by histology. Using CEUS thyroid carcinomas in 19 patients showed early and irregular arterial vascularization followed by early arterial central wash-out. CCDS/PD, however, revealed irregular peripheral vascularization with low flow only in 8 cases. Further analysis resulted in a significant higher area under the curve (AUC) at the edge than in the tumor center but in a similar time to peak (TTP) in both regions.

Conclusions: CEUS represents a highly sensitive method for the detection of the microvascularization of thyroid carcinomas. Future studies should compare these findings to benign pathologies in order to establish CEUS as a standard diagnostic procedure in the preoperative evaluation of suspicious thyroid nodules.

Citing Articles

Significance of maximum intensity projection technique of multimodal ultrasound imaging in differentiating follicular thyroid carcinoma from benign lesions.

Gao W, Chen Y, Wu Q, Li Y, Zheng Y, Wang Y Front Oncol. 2024; 14:1407611.

PMID: 39301550 PMC: 11410567. DOI: 10.3389/fonc.2024.1407611.


Integrated use of contrast-enhanced and grey-scale ultrasound in assigning American College of Radiology Thyroid Imaging-Reporting and Data System scores for characterisation of thyroid nodules: A prospective observational study.

Verma A, Krishna K A, Kumar I, Singh P, Kar A, Agrawal N Ultrasound. 2024; 32(3):140-149.

PMID: 39100794 PMC: 11292930. DOI: 10.1177/1742271X231225056.


The Utility of Contrast-Enhanced Ultrasound (CEUS) in Assessing the Risk of Malignancy in Thyroid Nodules.

Zylka A, Dobruch-Sobczak K, Piotrzkowska-Wroblewska H, Jedrzejczyk M, Bakula-Zalewska E, Goralski P Cancers (Basel). 2024; 16(10).

PMID: 38791990 PMC: 11119249. DOI: 10.3390/cancers16101911.


The value of conventional ultrasound combined with superb microvascular imaging and color Doppler flow imaging in the diagnosis of thyroid malignant nodules: a systematic review and meta-analysis.

Jiang L, Zhang D, Chen Y, Yu X, Pan M, Lian L Front Endocrinol (Lausanne). 2023; 14:1182259.

PMID: 37415660 PMC: 10321595. DOI: 10.3389/fendo.2023.1182259.


Benefits of Contrast-Enhanced Ultrasonography to the Differential Diagnosis of TI-RADS 4-5 Thyroid Nodules.

Yu P, Niu S, Gao S, Tian H, Zhu J Appl Bionics Biomech. 2022; 2022:7386516.

PMID: 35465180 PMC: 9033405. DOI: 10.1155/2022/7386516.